Kerry A Rogers, MD
Ohio State University Comprehensive Cancer Center · Ohio State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kerry A Rogers, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:52 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07734038 · Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaKerry Rogers · recruiting · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · principal investigator
- Ph2NCT06466122 · Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKiKerry Rogers · recruiting · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma · principal investigator
- Ph2NCT03943342 · Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib ResistanceKerry Rogers · withdrawn · Chronic Lymphocytic Leukemia, Loss of Chromosome 17p · principal investigator
- Ph1/Ph2NCT02557516 · Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLLInnate Pharma · terminated · Chronic Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:52 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Transcatheter Mitral-Valve Repair in Patients with Heart Failure.N Engl J Med · 20182,451 citationsRCR 108.4
- Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.N Engl J Med · 2023314 citationsRCR 34.7
- Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.Cancer Discov · 2023131 citationsRCR 8.5
- One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.Circulation · 2019124 citationsRCR 5.3
- Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.N Engl J Med · 202663 citationsRCR 31.5
- 41 citationsRCR 6.5
- 20 citationsRCR 10.0
- 10 citationsRCR 5.0
- 4 citationsRCR 0.5
- Predictive value of platelet function assays in traumatic brain injury patients on antiplatelet therapy.J Trauma Acute Care Surg · 20254 citationsRCR 2.0